Vaccine Maker Sinovac Enters Into Joint Venture In Chinese Coastal City Of Dalian
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Flush with cash following strong earnings for the third quarter and rising sales of the seasonal influenza vaccine Anflu, Beijing-based Sinovac Biotech aims to expand operations by investing in a joint venture in the Northeastern coastal city of Dalian, the company announced Nov. 25